BioSpace News Archive

GT Biopharma, Inc., a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer cell engager, TriKE® platform, issued an open letter from the CEO to shareholders, detailing the Company’s recent activities.

SABI Mind is the first clinical site in Alberta to be approved for a study investigating psychedelic-assisted psychotherapy in the treatment of individuals with Alcohol Use Disorder (AUD).

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (“PCR”)-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023.

Intelivation Technologies, a medical device company with a cutting-edge spinal and orthopedic implant product portfolio, announced that they have added a strategic member to the team with the hiring of Dennis Jones as the VP of Manufacturing.

ams OSRAM, a global leader in optical solutions, introduced the AS5911, a 256-channel analog-to-digital converter for digitizing signals from photodiode arrays in high-performance computed tomography scanners.

Medline announced a new partnership with MDHearing, a direct-to-consumer hearing aid manufacturer, to make it easier for people to purchase affordable hearing aids without a prescription.

Life Science Intelligence, the Medtech Market Intelligence company, announced an expanded partnership with MedtechWomen, the leading organization dedicated to highlighting and connecting women leaders in medtech.

Rosalind Franklin University of Medicine and Science (RFU) announced today that one of its early-stage companies — Resuscitation Therapeutics (RTx), which is focused on developing new therapies for life-threatening acute cardiovascular events — is preparing an Investigational New Drug (IND) application for submission to the U.S. Food and Drug Administration proposing a novel treatment for sudden cardiac arrest (SCA).

ASPIVIX SA today announced that Carevix™, its novel Cervical Stabilizer, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, today announced FDA approval of its innovative second generation GENOSYL® Inhaled Nitric Oxide (iNO) delivery system for use with rebreathing anesthesia in the operating room setting.